B02AB Proteinase inhibitors, antifibrinolytic
ATC group of level 4 – chemical subgroup · in plain English: medicines to stop bleeding
This site has the patient leaflet or the SPC of 2 medicines in this group and its subgroups.
- 1 prescription only (POM)
Active substance: Human alpha1-proteinase inhibitor – all medicines with this substance, also in combinations.
Place in the ATC classification
- B Blood and blood forming organ drugs 1,013 medicines
- B02 Antihemorrhagics 196 medicines
- B02A Antifibrinolytics 15 medicines
-
B02AB Proteinase inhibitors, antifibrinolytic 2 medicines
- B02AB01 aprotinin 1 medicine
- B02AB02 alfa1 antitrypsin 1 medicine
-
B02AB Proteinase inhibitors, antifibrinolytic 2 medicines
- B02A Antifibrinolytics 15 medicines
- B02 Antihemorrhagics 196 medicines
2 more subgroups have no medicine with a leaflet on this site.
Medicines in the group and its subgroups
| Medicine | Legal category |
|---|---|
| Aprotinin 10 000 Kiu/ml injection BP SPC (B02AB01 aprotinin) | – |
| Respreeza 1000 mg powder and solvent for solution for injection SPC (B02AB02 alfa1 antitrypsin) | Prescription only (POM) |
Other groups of the same level
- B02AA Antifibrinolytic amino acids 13 medicines
Other names of the ATC group
- Czech: B02AB Inhibitory proteáz
- French: B02AB inhibiteurs de protéinases
- German: B02AB Proteinasehemmer
- German: B02AB Proteinasehemmer
- Italian: B02AB GABESATO MESILATO
- Polish: B02AB Inhibitory proteazy
- Turkish: B02AB Proteinaz inhibitörleri, antifibrinolitik
- Portuguese (Brazil): B02AB Inibidores de Proteinase
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group B02AB
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
